Table 1.
IPA category | Pathway −log (P-valuea) |
Gene symbol |
Molecules in dataset | Ratio |
---|---|---|---|---|
BRCA1-mediated | 1.41E00 | CXCR2 | Chemokine (C-X-C motif) receptor 2 | 6.56E-02 |
NOX4 | NADPH oxidase 4 | |||
FLT4 | Fms-related tyrosine kinase 4 | |||
BCL-2 | B-cell CLL/lymphoma 2 | |||
MAP2K1 | Mitogen-activated protein kinase kinase 1 | |||
ATM | ATMserine/threonine kinase | |||
BAX | BCL-2 associated X protein | |||
PIK3CB | Phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta | |||
GNG11 | Guanine nucleotide binding protein (G protein), gamma11 | |||
GNG2 | Guanine nucleotide binding protein (G protein), gamma 2 | |||
GNAI1 | Guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1 |
|||
LIMK2 | LIM domain kinase 2 | |||
PTGS2 | prostaglandin-endoperoxide synthase 2 |
Abbreviations: FDR, false discovery rate; IPA, ingenuity pathway analysis.
Fischer’s exact test was used to calculate the P-value, determining the probability that the association between the genes in the data set and the canonical pathway is explained by chance alone. To account for multiple canonical pathways tested by IPA, the FDR option was used (FDR<0.1).